SGRY Stock Analysis: Buy, Sell, or Hold?
SGRY - Surgery Partners, Inc. Common Stock
$15.40
-0.50 (-3.14%)
▼
5d:
-2.1%
30d:
-7.23%
90d:
+9.76%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 10, 2026
6d
Smart Money Distribution
None View Scanner →
Strength: 4.8/10
Get Alerted When SGRY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SGRY shows positive signals but monitor for confirmation. Market pricing in 3.0% decline. Moderate conviction.
💡 BUY OPPORTUNITY: SGRY shows positive signals but monitor for confirmation. Market pricing in 3.0% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$32.55
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.21
23.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SGRY is currently trading at $15.40, which is considered slightly high relative to its 30-day fair value range of $15.25 to $16.74. The stock's valuation (Forward PE: 23.0) is in line with its historical norms (25.2). Remarkably, the market is currently pricing in an annual earnings decline of 3.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SGRY is in a strong uptrend. Immediate support is located at $14.87, while resistance sits at $16.64. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.64 (+21.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SGRY is in a strong uptrend. Immediate support is located at $14.87, while resistance sits at $16.64. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $18.64 (+21.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$15.25 -
$16.74
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading 21.0% below Wall St target ($18.64)
Trading Range Analysis
30-Day Trading Range
$15.25 -
$16.74
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$14.87
Resistance Level
$16.64
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.03
Wall Street Target
$18.64
(+21.0%)
Revenue Growth (YoY)
4.5%
Profit Margin
-2.3%
Valuation Discount vs History
-3.0% cheaper
PE vs Historical
23.0 vs 25.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.0%
(market-implied from PE analysis)
1-Year Target
$14.94
(-3%)
2-Year Target
$14.49
(-6%)
3-Year Target
$14.06
(-9%)
3-Yr Target (if PE normalizes)
(PE: 23→25)
$15.38
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.0, Growth: 43.9%)
$45.93
(+198%)
Base:
(SPY PE: 20.7, Growth: 43.9%)
$41.33
(+168%)
Bear:
(PE: 17.6, Growth: 43.9%)
$35.13
(+128%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 23.0 to 25.2
Stabilization Target:
$16.85
(+9.4%)
PE Expansion Potential:
+9.4%
Share & Embed Analysis
Last updated: August 03, 2026 12:59 AM ET
Data refreshes hourly during market hours. Next update: 1:59 AM
Data refreshes hourly during market hours. Next update: 1:59 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SGRY showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
David T Doherty
SELL
8867 shares
2026-03-16
Jason Eric Evans
SELL
20400 shares
2026-03-16
Danielle Burkhalter
SELL
3469 shares
2026-03-13
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$277 | 52 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$453 | 47 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 46 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 47 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$33 | 61 BUY |
Advanced SGRY Option Strategies
Professional options setups generated by AI based on today's SGRY price and gamma walls.
